Documentos e informes
-
Health provider payment reforms in China : what international experience tells us (Vol. 1 of 2) : Executive summary (Chino)
This paper examines health provider payment reforms in China the present system and how it evolved, and changes that will improve it in the context of ongoing health reform. The paper begins with a brief...
Tipo de documento: Documento de trabajo (Serie Numerada) Número del informe: 58414 Fecha del documento: 1 de julio de 2010 Tipo de divulgación: Disclosed
-
Health provider payment reforms in China : what international experience tells us (Vol. 1 of 2) : Executive summary (Inglés)
This paper examines health provider payment reforms in China the present system and how it evolved, and changes that will improve it in the context of ongoing health reform. The paper begins with a brief...
Tipo de documento: Documento de trabajo (Serie Numerada) Número del informe: 58414 Fecha del documento: 1 de julio de 2010 Tipo de divulgación: Disclosed
-
Health provider payment reforms in China : what international experience tells us (Vol. 2 of 2) : Main report (Inglés)
This paper examines health provider payment reforms in China the present system and how it evolved, and changes that will improve it in the context of ongoing health reform. The paper begins with a brief...
Tipo de documento: Documento de trabajo (Serie Numerada) Número del informe: 58414 Fecha del documento: 1 de julio de 2010 Tipo de divulgación: Disclosed
-
The path to integrated insurance system in China (Vol. 2 of 2) : Main report (Inglés)
Since the 2003 Severe Acute Respiratory Syndrome (SARS) outbreak, health care in China has become a leading national concern. Often highlighted by the popular phrase, kan-bing-nan, kan-bing-gui (seeking...
Tipo de documento: Documento de trabajo (Serie Numerada) Número del informe: 58412 Fecha del documento: 1 de junio de 2010 Tipo de divulgación: Disclosed
-
A generic drug policy as cornerstone to essential medicines in China (Vol. 1 of 2) : Executive summary (Chino)
Compared with developed economies, health expenditure in China is not particularly high on a per capita basis or as a share of Gross Domestic Product (GDP). Similarly, pharmaceutical expenditure in comparative...
Tipo de documento: Documento de trabajo (Serie Numerada) Número del informe: 58413 Fecha del documento: 1 de junio de 2010 Tipo de divulgación: Disclosed
-
Fixing the public hospital system in China (Vol. 2 of 2) (Chino)
In recent years, Chinese health care has improved rapidly, especially in the areas of equity and accessibility of services, as well as the movement toward universal coverage. A new round of health care...
Tipo de documento: Documento de trabajo (Serie Numerada) Número del informe: 58411 Fecha del documento: 1 de junio de 2010 Tipo de divulgación: Disclosed
-
The path to integrated insurance system in China (Vol. 1 of 2) : Executive summary (Chino)
Since the 2003 Severe Acute Respiratory Syndrome (SARS) outbreak, health care in China has become a leading national concern. Often highlighted by the popular phrase, kan-bing-nan, kan-bing-gui (seeking...
Tipo de documento: Documento de trabajo (Serie Numerada) Número del informe: 58412 Fecha del documento: 1 de junio de 2010 Tipo de divulgación: Disclosed
-
Fixing the public hospital system in China (Vol. 2 of 2) : Main report (Inglés)
In recent years, Chinese health care has improved rapidly, especially in the areas of equity and accessibility of services, as well as the movement toward universal coverage. A new round of health care...
Tipo de documento: Documento de trabajo (Serie Numerada) Número del informe: 58411 Fecha del documento: 1 de junio de 2010 Tipo de divulgación: Disclosed
-
Fixing the public hospital system in China (Vol. 1 of 2) : Executive summary (Chino)
In recent years, Chinese health care has improved rapidly, especially in the areas of equity and accessibility of services, as well as the movement toward universal coverage. A new round of health care...
Tipo de documento: Documento de trabajo (Serie Numerada) Número del informe: 58411 Fecha del documento: 1 de junio de 2010 Tipo de divulgación: Disclosed
-
Financing, pricing, and utilization of pharmaceuticals in China : the road to reform policy (Vol. 1 of 2) : Executive summary (Inglés)
This paper examines the financing, pricing, and utilization of pharmaceuticals in China the pharmaceutical system as it has evolved, and some changes that would improve it in the context of the national...
Tipo de documento: Documento de trabajo (Serie Numerada) Número del informe: 58410 Fecha del documento: 1 de junio de 2010 Tipo de divulgación: Disclosed Autor: Hu,Shanlian
-
The path to integrated insurance system in China (Vol. 2 of 2) : Main report (Chino)
Since the 2003 Severe Acute Respiratory Syndrome (SARS) outbreak, health care in China has become a leading national concern. Often highlighted by the popular phrase, kan-bing-nan, kan-bing-gui (seeking...
Tipo de documento: Documento de trabajo (Serie Numerada) Número del informe: 58412 Fecha del documento: 1 de junio de 2010 Tipo de divulgación: Disclosed
-
A generic drug policy as cornerstone to essential medicines in China (Vol. 2 of 2) : Main report (Inglés)
Compared with developed economies, health expenditure in China is not particularly high on a per capita basis or as a share of Gross Domestic Product (GDP). Similarly, pharmaceutical expenditure in comparative...
Tipo de documento: Documento de trabajo (Serie Numerada) Número del informe: 58413 Fecha del documento: 1 de junio de 2010 Tipo de divulgación: Disclosed
-
Fixing the public hospital system in China (Vol. 1 of 2) : Executive summary (Inglés)
In recent years, Chinese health care has improved rapidly, especially in the areas of equity and accessibility of services, as well as the movement toward universal coverage. A new round of health care...
Tipo de documento: Documento de trabajo (Serie Numerada) Número del informe: 58411 Fecha del documento: 1 de junio de 2010 Tipo de divulgación: Disclosed
-
Financing, pricing, and utilization of pharmaceuticals in China : the road to reform policy (Vol. 2 of 2) : Main report (Inglés)
This paper examines the financing, pricing, and utilization of pharmaceuticals in China the pharmaceutical system as it has evolved, and some changes that would improve it in the context of the national...
Tipo de documento: Documento de trabajo (Serie Numerada) Número del informe: 58410 Fecha del documento: 1 de junio de 2010 Tipo de divulgación: Disclosed Autor: Hu,Shanlian
-
Financing, pricing, and utilization of pharmaceuticals in China : the road to reform policy (Vol. 1 of 2) : Executive summary (Chino)
This paper examines the financing, pricing, and utilization of pharmaceuticals in China the pharmaceutical system as it has evolved, and some changes that would improve it in the context of the national...
Tipo de documento: Documento de trabajo (Serie Numerada) Número del informe: 58410 Fecha del documento: 1 de junio de 2010 Tipo de divulgación: Disclosed Autor: Hu,Shanlian
-
The path to integrated insurance system in China (Vol. 1 of 2) : Executive summary (Inglés)
Since the 2003 Severe Acute Respiratory Syndrome (SARS) outbreak, health care in China has become a leading national concern. Often highlighted by the popular phrase, kan-bing-nan, kan-bing-gui (seeking...
Tipo de documento: Documento de trabajo (Serie Numerada) Número del informe: 58412 Fecha del documento: 1 de junio de 2010 Tipo de divulgación: Disclosed
-
A generic drug policy as cornerstone to essential medicines in China (Vol. 1 of 2) : Executive summary (Inglés)
Compared with developed economies, health expenditure in China is not particularly high on a per capita basis or as a share of Gross Domestic Product (GDP). Similarly, pharmaceutical expenditure in comparative...
Tipo de documento: Documento de trabajo (Serie Numerada) Número del informe: 58413 Fecha del documento: 1 de junio de 2010 Tipo de divulgación: Disclosed
-
Financing, pricing, and utilization of pharmaceuticals in China : the road to reform policy (Vol. 2 of 2) : Main report (Chino)
This paper examines the financing, pricing, and utilization of pharmaceuticals in China the pharmaceutical system as it has evolved, and some changes that would improve it in the context of the national...
Tipo de documento: Documento de trabajo (Serie Numerada) Número del informe: 58410 Fecha del documento: 1 de junio de 2010 Tipo de divulgación: Disclosed Autor: Hu,Shanlian
-
Health provider payment reforms in China : what international experience tells us (Vol. 2 of 2) : Main report (Chino)
This paper examines health provider payment reforms in China the present system and how it evolved, and changes that will improve it in the context of ongoing health reform. The paper begins with a brief...
Tipo de documento: Documento de trabajo (Serie Numerada) Número del informe: 58414 Fecha del documento: 1 de enero de 2010 Tipo de divulgación: Disclosed
-
A generic drug policy as cornerstone to essential medicines in China (Vol. 2 of 2) : Main report (Chino)
Compared with developed economies, health expenditure in China is not particularly high on a per capita basis or as a share of Gross Domestic Product (GDP). Similarly, pharmaceutical expenditure in comparative...
Tipo de documento: Documento de trabajo (Serie Numerada) Número del informe: 58413 Fecha del documento: 1 de enero de 2010 Tipo de divulgación: Disclosed